INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$19.6M

$19,563,286

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
ARWR S ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard • CEO 10b5-1 Sell 2025-12-22 $861,340x2 View Form 4 →
ARWR	ARROWHEAD PHARMACEUTICALS, INC.	Anzalone Christopher Richard CEO 10b5-1 Sell	2025-12-22	$861,340x2	S	Form 4
ARWR S ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard • CEO 10b5-1 Sell 2025-12-19 $909,683x3 View Form 4 →
ARWR	ARROWHEAD PHARMACEUTICALS, INC.	Anzalone Christopher Richard CEO 10b5-1 Sell	2025-12-19	$909,683x3	S	Form 4
ARWR S ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard • CEO Discretionary Sell 2025-12-17 $5,443,462Whalex4 View Form 4 →
ARWR	ARROWHEAD PHARMACEUTICALS, INC.	Anzalone Christopher Richard CEO Discretionary Sell	2025-12-17	$5,443,462Whalex4	S	Form 4
ARWR S ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard • CEO Discretionary Sell 2025-12-16 $3,398,187Largex9 View Form 4 →
ARWR	ARROWHEAD PHARMACEUTICALS, INC.	Anzalone Christopher Richard CEO Discretionary Sell	2025-12-16	$3,398,187Largex9	S	Form 4
ARWR S ARROWHEAD PHARMACEUTICALS, INC. Anzalone Christopher Richard • CEO Discretionary Sell 2025-12-15 $8,950,615Whalex3 View Form 4 →
ARWR	ARROWHEAD PHARMACEUTICALS, INC.	Anzalone Christopher Richard CEO Discretionary Sell	2025-12-15	$8,950,615Whalex3	S	Form 4